NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in NextCure, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +2 vs. Q3 2024
- Shares held
- 16.0M
- +170.4K (+1.1%) vs. Q3 2024
- Total value
- $13.1M
- −$8.60M (−39.6%) vs. Q3 2024
- New holders
- 8
- 6 more added
- Sold out
- 6
- 13 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sofinnova Investments, Inc. | 2,671,856 | $2.06M | 0.15% | 00.0% | Unchanged |
| Pfizer Inc | 1,458,550 | $1.89M | 0.07% | +1,458,550 | New |
| Affinity Asset Advisors, LLC | 2,302,598 | $1.78M | 0.28% | 00.0% | Unchanged |
| Citigroup Inc | 1,389,040 | $1.07M | 0.00% | +1,389,040 | New |
| OrbiMed Advisors LLC | 1,141,200 | $879.9K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 987,324 | $761.2K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 727,579 | $561.0K | 0.00% | −2,257−0.3% | Reduced |
| Tang Capital Management LLC | 700,000 | $539.7K | 0.04% | +47,614+7.3% | Added |
| Cable Car Capital LLC | 615,878 | $474.8K | 0.04% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 519,300 | $400.4K | 0.00% | +113,300+27.9% | Added |
| Acadian Asset Management LLC | 488,440 | $375.0K | 0.00% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 403,698 | $311.3K | 0.31% | +403,698 | New |
| Federated Hermes, Inc. | 315,180 | $243.0K | 0.00% | −6,347−2.0% | Reduced |
| BML Capital Management, LLC | 273,536 | $210.9K | 0.13% | −2,929−1.1% | Reduced |
| Cardiff Park Advisors, LLC | 262,000 | $202.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 233,914 | $180.4K | 0.00% | +10,173+4.5% | Added |
| Long Focus Capital Management, LLC | 185,936 | $143.4K | 0.01% | −370,169−66.6% | Reduced |
| Macquarie Group Ltd | 150,000 | $116.0K | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 130,000 | $100.2K | 0.03% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 120,012 | $92.5K | 0.02% | −10.0% | Reduced |
| Hudson Bay Capital Management LP | 107,672 | $83.0K | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 104,000 | $80.2K | 0.00% | +4,000+4.0% | Added |
| Dimensional Fund Advisors LP | 85,853 | $66.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 78,678 | $60.7K | 0.00% | +22,724+40.6% | Added |
| Bridgeway Capital Management, LLC | 67,600 | $52.1K | 0.00% | −3,000−4.2% | Reduced |
| Barclays PLC | 67,518 | $52.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 65,392 | $50.4K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 58,259 | $44.9K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 48,186 | $37.2K | 0.00% | +48,186 | New |
| Northern Trust Corp | 47,493 | $36.6K | 0.00% | −69−0.1% | Reduced |
| Millennium Management LLC | 42,517 | $32.8K | 0.00% | −29,602−41.0% | Reduced |
| Ieq Capital, LLC | 37,342 | $28.8K | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 25,000 | $19.3K | 0.02% | +25,000 | New |
| Virtu Financial LLC | 22,951 | $18.0K | 0.00% | +22,951 | New |
| Schonfeld Strategic Advisors LLC | 21,800 | $16.8K | 0.00% | −2,000−8.4% | Reduced |
| LPL Financial LLC | 20,500 | $15.8K | 0.00% | −6,500−24.1% | Reduced |
| Engineers Gate Manager LP | 20,198 | $15.6K | 0.00% | +9,424+87.5% | Added |
| HSBC Holdings PLC | 17,363 | $13.7K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 13,577 | $10.5K | 0.00% | +13,577 | New |
| UBS Group AG | 4,202 | $3.24K | 0.00% | −1,264−23.1% | Reduced |
| Advisor Group Holdings, Inc. | 1,191 | $917 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 805 | $621 | 0.00% | −2−0.2% | Reduced |
| Tower Research Capital LLC (TRC) | 658 | $508 | 0.00% | +658 | New |
| BNP Paribas Arbitrage, SA | 385 | $297 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 252 | $194 | 0.00% | −5,138−95.3% | Reduced |
| Morgan Stanley | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Logos Global Management LP | 0 | $0 | 0.00% | −2,500,000−100.0% | Sold out |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −342,592−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −85,308−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −21,247−100.0% | Sold out |
| HarbourVest Partners LLC | 0 | $0 | 0.00% | −10,044−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |